The Global X HealthTech ETF (HEAL) seeks to provide exposure to companies driving healthcare's technological revolution. By Arelis Agosto

By leveraging advances in genomics and artificial intelligence, companies working to treat cancer can tap into numerous potential growth drivers. By Arelis Agosto

Novel therapeutic agents can differentiate themselves via a host of factors, which can also have notable implications on potential revenue opportunities. By Arelis Agosto

Drug development is key to pharmaceutical industry success, and it’s crucial for investors to understand a drug’s lifecycle to navigate this dynamic sector. By Arelis Agosto

GLP-1s have already seen enormous success treating obesity and diabetes, and their achievements could be replicated in other illnesses. By Arelis Agosto